(VIANEWS) – Good morning! Another day of trading is almost starting and here’s today’s list of stocks that have had significant trading activity in the US premarket session.

The three most active and biggest winners today are 10x Genomics, argenx SE, and Nautilus.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 10x Genomics (TXG) 49.04 4.52% 2022-07-14 07:04:35
2 argenx SE (ARGX) 366.84 3.42% 2022-07-14 07:23:08
3 Nautilus (NLS) 2.11 2.93% 2022-07-14 07:31:31
4 Xenetic Biosciences (XBIO) 0.94 1.84% 2022-07-14 04:19:33
5 Inovio Pharmaceuticals (INO) 2.14 0.47% 2022-07-14 07:27:48
6 Advanced Semiconductor Engineering (ASX) 5.11 0.39% 2022-07-14 07:09:59
7 U.S. Gold Corp (USAU) 3.70 0.27% 2022-07-14 07:04:48
8 Trimble (TRMB) 57.55 0.23% 2022-07-14 04:15:13
9 Charles River Laboratories (CRL) 214.39 0.11% 2022-07-14 04:21:47
10 Xylem (XYL) 76.03 0.04% 2022-07-14 04:42:22

The three most active and biggest losers today are FAT Brands, Nokia, and Kosmos Energy.

Rank Financial Asset Price Premarket
Change
Updated (EST)
1 FAT Brands (FAT) 7.35 -3.92% 2022-07-14 07:02:31
2 Nokia (NOK) 4.43 -3.7% 2022-07-14 07:31:36
3 Kosmos Energy (KOS) 5.09 -3.23% 2022-07-14 07:30:18
4 VALE (VALE) 13.03 -3.19% 2022-07-14 07:20:10
5 Kinross Gold (KGC) 3.25 -2.99% 2022-07-14 07:30:00
6 Yamana Gold (AUY) 4.70 -2.89% 2022-07-14 06:54:39
7 Cenovus Energy (CVE) 16.02 -2.61% 2022-07-14 07:27:06
8 Lloyds Banking Group (LYG) 1.94 -2.51% 2022-07-14 07:15:37
9 Freeport (FCX) 25.64 -2.47% 2022-07-14 07:28:14
10 Carnival Plc (CUK) 7.93 -2.34% 2022-07-14 07:22:30

Most Active Premarket Winners today

1. 10x Genomics (TXG) – Premarket: 4.52%

NASDAQ ended the session with 10x Genomics dropping 1.59% to $46.92 on Thursday, after two sequential sessions in a row of losses. NASDAQ fell 0% to $0.00, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for 10x Genomics is 633570, 61.5% below its average volume of 1645790.

10x Genomics’s last close was $46.92, 77.55% below its 52-week high of $208.99.

10x Genomics’s Sales

10x Genomics’s sales growth is 78.1% for the current quarter and 33.2% for the next. The company’s growth estimates for the current quarter and the next is 70.8% and 97.2%, respectively.

10x Genomics’s Revenue

Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.

Volatility

10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.16%, a positive 1.37%, and a positive 4.99%, respectively.

10x Genomics’s highest amplitude of average volatility was 3.93% (last week), 4.55% (last month), and 4.99% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

10x Genomics’s stock is considered to be overbought (>=80).

10x Genomics’s Stock Yearly Top and Bottom Value

10x Genomics’s stock is valued at $46.92 at 08:34 EST, way below its 52-week low of $128.15.

10x Genomics’s Moving Average

10x Genomics’s value is way under its 50-day moving average of $155.93 and way below its 200-day moving average of $170.12.

More news about 10x Genomics.

2. argenx SE (ARGX) – Premarket: 3.42%

NASDAQ ended the session with argenx SE jumping 0.67% to $354.71 on Thursday while NASDAQ fell 0% to $0.00.

Volume

Today’s last reported volume for argenx SE is 256861, 25.4% below its average volume of 344321.

argenx SE’s last close was $354.71, 7.58% under its 52-week high of $383.81.

The company’s growth estimates for the present quarter and the next is a negative 345.5% and a negative 22.7%, respectively.

argenx SE’s Revenue

Year-on-year quarterly revenue growth grew by 241.4%, now sitting on 528.27M for the twelve trailing months.

Volatility

argenx SE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.91%, a positive 0.40%, and a positive 2.61%, respectively.

argenx SE’s highest amplitude of average volatility was 1.72% (last week), 2.37% (last month), and 2.61% (last quarter), respectively.

argenx SE’s Stock Yearly Top and Bottom Value

argenx SE’s stock is valued at $354.71 at 08:34 EST, under its 52-week high of $383.81 and way higher than its 52-week low of $249.50.

argenx SE’s Moving Average

argenx SE’s worth is higher than its 50-day moving average of $327.19 and way higher than its 200-day moving average of $307.23.

More news about argenx SE.

3. Nautilus (NLS) – Premarket: 2.93%

NYSE ended the session with Nautilus jumping 10.22% to $2.05 on Thursday, after four consecutive sessions in a row of gains. NYSE fell 0.38% to $14,340.29, after four successive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Nautilus is 540202, 42.41% below its average volume of 938138.

Nautilus’s last close was $2.05, 87.7% under its 52-week high of $16.67.

Nautilus’s Sales

Nautilus’s sales growth is a negative 41% for the present quarter and a decline by 31.7% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 161.7% and a negative 172.1%, respectively.

Nautilus’s Revenue

Year-on-year quarterly revenue growth declined by 22.2%, now sitting on 664.91M for the twelve trailing months.

Volatility

Nautilus’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.56%, a negative 0.78%, and a positive 4.70%, respectively.

Nautilus’s highest amplitude of average volatility was 4.45% (last week), 4.15% (last month), and 4.70% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Nautilus’s stock is considered to be overbought (>=80).

Nautilus’s Stock Yearly Top and Bottom Value

Nautilus’s stock is valued at $2.05 at 08:34 EST, way below its 52-week high of $16.67 and way above its 52-week low of $1.70.

Nautilus’s Moving Average

Nautilus’s worth is way under its 50-day moving average of $2.46 and way under its 200-day moving average of $5.61.

More news about Nautilus.

4. Xenetic Biosciences (XBIO) – Premarket: 1.84%

NASDAQ ended the session with Xenetic Biosciences rising 5.56% to $0.92 on Thursday while NASDAQ dropped 0% to $0.00.

Volume

Today’s last reported volume for Xenetic Biosciences is 67766, 55.82% below its average volume of 153405.

Xenetic Biosciences’s last close was $0.92, 83.75% below its 52-week high of $5.68.

Xenetic Biosciences’s Sales

Xenetic Biosciences’s sales growth is 72.4% for the current quarter and a decline by 33.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 90% and 6.3%, respectively.

Xenetic Biosciences’s Revenue

Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.

Volatility

Xenetic Biosciences’s last week, last month’s, and last quarter’s current intraday variation average was 3.42%, 1.67%, and 3.74%, respectively.

Xenetic Biosciences’s highest amplitude of average volatility was 4.79% (last week), 3.15% (last month), and 3.74% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xenetic Biosciences’s stock is considered to be oversold (<=20).

Xenetic Biosciences’s Stock Yearly Top and Bottom Value

Xenetic Biosciences’s stock is valued at $0.92 at 08:34 EST, way below its 52-week low of $1.21.

Xenetic Biosciences’s Moving Average

Xenetic Biosciences’s value is way below its 50-day moving average of $1.64 and way under its 200-day moving average of $2.19.

More news about Xenetic Biosciences.

5. Inovio Pharmaceuticals (INO) – Premarket: 0.47%

NASDAQ ended the session with Inovio Pharmaceuticals rising 6.25% to $2.13 on Thursday while NASDAQ fell 0% to $0.00.

Volume

Today’s last reported volume for Inovio Pharmaceuticals is 5181330, 21.2% below its average volume of 6575730.

Inovio Pharmaceuticals’s last close was $2.13, 78.61% under its 52-week high of $9.96.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is 138.1% for the present quarter and a decline by 33% for the next. The company’s growth estimates for the current quarter is 17.9% and a drop 3.4% for the next.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 85%, now sitting on 1.77M for the twelve trailing months.

Volatility

Inovio Pharmaceuticals’s last week, last month’s, and last quarter’s current intraday variation average was 0.21%, 2.12%, and 6.16%, respectively.

Inovio Pharmaceuticals’s highest amplitude of average volatility was 5.99% (last week), 5.35% (last month), and 6.16% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Inovio Pharmaceuticals’s stock is considered to be oversold (<=20).

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $2.13 at 08:34 EST, way under its 52-week high of $9.96 and way above its 52-week low of $1.38.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s value is under its 50-day moving average of $2.20 and way below its 200-day moving average of $4.61.

More news about Inovio Pharmaceuticals.

6. Advanced Semiconductor Engineering (ASX) – Premarket: 0.39%

NYSE ended the session with Advanced Semiconductor Engineering jumping 0.59% to $5.09 on Thursday while NYSE fell 0.38% to $14,340.29.

Volume

Today’s last reported volume for Advanced Semiconductor Engineering is 3830870, 44.4% below its average volume of 6890690.

Advanced Semiconductor Engineering’s last close was $5.09, 47.09% below its 52-week high of $9.62.

Advanced Semiconductor Engineering’s Sales

Advanced Semiconductor Engineering’s sales growth is 13.8% for the ongoing quarter and 17.7% for the next. The company’s growth estimates for the ongoing quarter and the next is 43.8% and 28.6%, respectively.

Advanced Semiconductor Engineering’s Revenue

Year-on-year quarterly revenue growth grew by 20.9%, now sitting on 594.92B for the twelve trailing months.

Volatility

Advanced Semiconductor Engineering’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.11%, a negative 1.65%, and a positive 2.76%, respectively.

Advanced Semiconductor Engineering’s highest amplitude of average volatility was 1.09% (last week), 2.88% (last month), and 2.76% (last quarter), respectively.

Advanced Semiconductor Engineering’s Stock Yearly Top and Bottom Value

Advanced Semiconductor Engineering’s stock is valued at $5.09 at 08:34 EST, way under its 52-week high of $9.62 and higher than its 52-week low of $4.88.

Advanced Semiconductor Engineering’s Moving Average

Advanced Semiconductor Engineering’s value is way below its 50-day moving average of $6.45 and way below its 200-day moving average of $7.11.

More news about Advanced Semiconductor Engineering.

7. U.S. Gold Corp (USAU) – Premarket: 0.27%

NASDAQ ended the session with U.S. Gold Corp dropping 0.54% to $3.68 on Thursday, after five successive sessions in a row of losses. NASDAQ fell 0% to $0.00, after three consecutive sessions in a row of losses, on what was a somewhat up trend trading session today.

Volume

Today’s last reported volume for U.S. Gold Corp is 27437, 34.58% below its average volume of 41946.

U.S. Gold Corp’s last close was $3.68, 78.85% under its 52-week high of $17.40.

Volatility

U.S. Gold Corp’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.15%, a negative 1.08%, and a positive 3.73%, respectively.

U.S. Gold Corp’s highest amplitude of average volatility was 3.15% (last week), 3.68% (last month), and 3.73% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

U.S. Gold Corp’s stock is considered to be overbought (>=80).

U.S. Gold Corp’s Stock Yearly Top and Bottom Value

U.S. Gold Corp’s stock is valued at $3.68 at 08:34 EST, way under its 52-week low of $8.50.

U.S. Gold Corp’s Moving Average

U.S. Gold Corp’s worth is way under its 50-day moving average of $10.13 and way below its 200-day moving average of $10.50.

More news about U.S. Gold Corp.

8. Trimble (TRMB) – Premarket: 0.23%

NASDAQ ended the session with Trimble sliding 0.17% to $57.42 on Thursday, after four sequential sessions in a row of losses. NASDAQ fell 0% to $0.00, after three successive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for Trimble is 480645, 57.91% below its average volume of 1142200.

Trimble’s last close was $57.42, 40.49% under its 52-week high of $96.49.

Trimble’s Sales

Trimble’s sales growth is 8.9% for the present quarter and 6.6% for the next. The company’s growth estimates for the current quarter is a negative 11.1% and positive 9.1% for the next.

Trimble’s Revenue

Year-on-year quarterly revenue growth grew by 11.6%, now sitting on 3.66B for the twelve trailing months.

Volatility

Trimble’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.24%, a negative 0.16%, and a positive 2.27%, respectively.

Trimble’s highest amplitude of average volatility was 1.24% (last week), 1.66% (last month), and 2.27% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Trimble’s stock is considered to be overbought (>=80).

Trimble’s Stock Yearly Top and Bottom Value

Trimble’s stock is valued at $57.42 at 08:34 EST, way under its 52-week high of $96.49 and above its 52-week low of $55.65.

Trimble’s Moving Average

Trimble’s value is below its 50-day moving average of $63.51 and way below its 200-day moving average of $74.41.

More news about Trimble.

9. Charles River Laboratories (CRL) – Premarket: 0.11%

NYSE ended the session with Charles River Laboratories sliding 1.44% to $214.39 on Thursday while NYSE slid 0.38% to $14,340.29.

Volume

Today’s last reported volume for Charles River Laboratories is 279908, 48.65% below its average volume of 545106.

Charles River Laboratories’s last close was $214.39, 53.41% below its 52-week high of $460.21.

Charles River Laboratories’s Sales

Charles River Laboratories’s sales growth is 26.5% for the present quarter and 17.6% for the next. The company’s growth estimates for the present quarter and the next is 10.7% and 7.9%, respectively.

Charles River Laboratories’s Revenue

Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 3.43B for the twelve trailing months.

Volatility

Charles River Laboratories’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.81%, a positive 0.18%, and a positive 2.81%, respectively.

Charles River Laboratories’s highest amplitude of average volatility was 2.39% (last week), 2.14% (last month), and 2.81% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Charles River Laboratories’s stock is considered to be overbought (>=80).

Charles River Laboratories’s Stock Yearly Top and Bottom Value

Charles River Laboratories’s stock is valued at $214.39 at 08:34 EST, below its 52-week low of $237.27.

Charles River Laboratories’s Moving Average

Charles River Laboratories’s worth is way below its 50-day moving average of $393.86 and way below its 200-day moving average of $371.52.

More news about Charles River Laboratories.

10. Xylem (XYL) – Premarket: 0.04%

NYSE ended the session with Xylem falling 0.98% to $76.03 on Thursday, after five successive sessions in a row of losses. NYSE dropped 0.38% to $14,340.29, after four consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Xylem is 546629, 51.83% below its average volume of 1134970.

Xylem’s last close was $76.03, 45.22% below its 52-week high of $138.78.

Xylem’s Sales

Xylem’s sales growth is 8.1% for the present quarter and 5.9% for the next. The company’s growth estimates for the ongoing quarter and the next is 3.2% and 2.5%, respectively.

Xylem’s Revenue

Year-on-year quarterly revenue growth grew by 3.7%, now sitting on 5.25B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Xylem’s stock is considered to be overbought (>=80).

Xylem’s Stock Yearly Top and Bottom Value

Xylem’s stock is valued at $76.03 at 08:34 EST, way under its 52-week low of $94.63.

Xylem’s Moving Average

Xylem’s worth is way below its 50-day moving average of $125.77 and way below its 200-day moving average of $120.36.

More news about Xylem.

Most Active Premarket Losers Today

1. FAT Brands (FAT) – Premarket: -3.92%

NASDAQ ended the session with FAT Brands dropping 0.52% to $7.65 on Thursday, following the last session’s downward trend. NASDAQ fell 0% to $0.00, after three consecutive sessions in a row of losses, on what was a somewhat bullish trend exchanging session today.

Volume

Today’s last reported volume for FAT Brands is 3082, 82.95% below its average volume of 18078.

FAT Brands’s last close was $7.65, 52.16% below its 52-week high of $15.99.

The company’s growth estimates for the present quarter and the next is a negative 83.3% and a negative 150%, respectively.

FAT Brands’s Revenue

Year-on-year quarterly revenue growth grew by 1041.5%, now sitting on 118.88M for the twelve trailing months.

Volatility

FAT Brands’s last week, last month’s, and last quarter’s current intraday variation average was 0.44%, 1.20%, and 3.30%, respectively.

FAT Brands’s highest amplitude of average volatility was 1.85% (last week), 2.43% (last month), and 3.30% (last quarter), respectively.

FAT Brands’s Stock Yearly Top and Bottom Value

FAT Brands’s stock is valued at $7.65 at 08:34 EST, way below its 52-week high of $15.99 and way higher than its 52-week low of $5.47.

FAT Brands’s Moving Average

FAT Brands’s worth is way higher than its 50-day moving average of $6.37 and way under its 200-day moving average of $8.82.

More news about FAT Brands.

2. Nokia (NOK) – Premarket: -3.7%

NYSE ended the session with Nokia rising 0.55% to $4.60 on Thursday while NYSE dropped 0.38% to $14,340.29.

Volume

Today’s last reported volume for Nokia is 23440800, 32.19% below its average volume of 34568600.

Nokia’s last close was $4.60, 28.13% under its 52-week high of $6.40.

Nokia’s Sales

Nokia’s sales growth is a negative 3.4% for the ongoing quarter and a decline by 1.6% for the next. The company’s growth estimates for the current quarter is a negative 9.1% and positive 22.2% for the next.

Nokia’s Revenue

Year-on-year quarterly revenue growth grew by 5.4%, now sitting on 22.47B for the twelve trailing months.

Volatility

Nokia’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.35%, a negative 0.13%, and a positive 1.91%, respectively.

Nokia’s highest amplitude of average volatility was 0.70% (last week), 1.43% (last month), and 1.91% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Nokia’s stock is considered to be overbought (>=80).

Nokia’s Stock Yearly Top and Bottom Value

Nokia’s stock is valued at $4.60 at 08:34 EST, way below its 52-week high of $6.40 and higher than its 52-week low of $4.51.

Nokia’s Moving Average

Nokia’s value is under its 50-day moving average of $4.90 and way below its 200-day moving average of $5.46.

More news about Nokia.

3. Kosmos Energy (KOS) – Premarket: -3.23%

NYSE ended the session with Kosmos Energy jumping 0.86% to $5.26 on Thursday, following the last session’s upward trend. NYSE dropped 0.38% to $14,340.29, after four consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Volume

Today’s last reported volume for Kosmos Energy is 3533530, 63.36% below its average volume of 9644270.

Kosmos Energy’s last close was $5.26, 38.04% under its 52-week high of $8.49.

Kosmos Energy’s Revenue

Year-on-year quarterly revenue growth grew by 108.9%, now sitting on 1.33B for the twelve trailing months.

Volatility

Kosmos Energy’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.31%, a negative 2.19%, and a positive 4.15%, respectively.

Kosmos Energy’s highest amplitude of average volatility was 3.31% (last week), 4.43% (last month), and 4.15% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Kosmos Energy’s stock is considered to be overbought (>=80).

Kosmos Energy’s Stock Yearly Top and Bottom Value

Kosmos Energy’s stock is valued at $5.26 at 08:34 EST, way under its 52-week high of $8.49 and way higher than its 52-week low of $1.80.

Kosmos Energy’s Moving Average

Kosmos Energy’s worth is way under its 50-day moving average of $7.08 and above its 200-day moving average of $5.14.

More news about Kosmos Energy.

4. VALE (VALE) – Premarket: -3.19%

NYSE ended the session with VALE rising 0.6% to $13.46 on Thursday, after two sequential sessions in a row of gains. NYSE slid 0.38% to $14,340.29, after four consecutive sessions in a row of losses, on what was a somewhat negative trend trading session today.

Volume

Today’s last reported volume for VALE is 21361700, 40.02% below its average volume of 35614900.

VALE’s last close was $13.46, 41.86% below its 52-week high of $23.15.

VALE’s Sales

VALE’s sales growth is a negative 17.7% for the present quarter and a decline by 4.5% for the next. The company’s growth estimates for the present quarter is a negative 24.8% and positive 44.7% for the next.

VALE’s Revenue

Year-on-year quarterly revenue growth declined by 17.6%, now sitting on 281.45B for the twelve trailing months.

Volatility

VALE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.71%, a negative 0.94%, and a positive 2.57%, respectively.

VALE’s highest amplitude of average volatility was 2.71% (last week), 2.84% (last month), and 2.57% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

VALE’s stock is considered to be overbought (>=80).

VALE’s Stock Yearly Top and Bottom Value

VALE’s stock is valued at $13.46 at 08:34 EST, way under its 52-week high of $23.15 and way above its 52-week low of $11.16.

VALE’s Moving Average

VALE’s value is way below its 50-day moving average of $16.28 and way below its 200-day moving average of $15.82.

More news about VALE.

5. Kinross Gold (KGC) – Premarket: -2.99%

NYSE ended the session with Kinross Gold rising 2.61% to $3.35 on Thursday, following the last session’s upward trend. NYSE slid 0.38% to $14,340.29, after four consecutive sessions in a row of losses, on what was a somewhat negative trend exchanging session today.

Volume

Today’s last reported volume for Kinross Gold is 17596100, 17.64% below its average volume of 21366300.

Kinross Gold’s last close was $3.35, 53.02% below its 52-week high of $7.13.

Kinross Gold’s Sales

Kinross Gold’s sales growth is a negative 17.6% for the current quarter and a decline by 18.8% for the next. The company’s growth estimates for the current quarter and the next is a negative 72% and a negative 70.4%, respectively.

Kinross Gold’s Revenue

Year-on-year quarterly revenue growth declined by 26.4%, now sitting on 3.73B for the twelve trailing months.

Volatility

Kinross Gold’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.31%, a negative 1.29%, and a positive 2.52%, respectively.

Kinross Gold’s highest amplitude of average volatility was 1.31% (last week), 2.66% (last month), and 2.52% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Kinross Gold’s stock is considered to be overbought (>=80).

Kinross Gold’s Stock Yearly Top and Bottom Value

Kinross Gold’s stock is valued at $3.35 at 08:34 EST, way under its 52-week low of $3.83.

Kinross Gold’s Moving Average

Kinross Gold’s value is way under its 50-day moving average of $4.73 and way under its 200-day moving average of $5.51.

More news about Kinross Gold.

6. Yamana Gold (AUY) – Premarket: -2.89%

NYSE ended the session with Yamana Gold jumping 2.76% to $4.84 on Thursday, following the last session’s upward trend. NYSE fell 0.38% to $14,340.29, after four sequential sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Yamana Gold is 18260200, 24.26% below its average volume of 24110200.

Yamana Gold’s last close was $4.84, 24.38% under its 52-week high of $6.40.

Yamana Gold’s Sales

Yamana Gold’s sales growth is 8.4% for the current quarter and 7.7% for the next.

Yamana Gold’s Revenue

Year-on-year quarterly revenue growth grew by 4.7%, now sitting on 1.84B for the twelve trailing months.

Volatility

Yamana Gold’s last week, last month’s, and last quarter’s current intraday variation average was 0.96%, 0.12%, and 2.56%, respectively.

Yamana Gold’s highest amplitude of average volatility was 2.02% (last week), 2.26% (last month), and 2.56% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Yamana Gold’s stock is considered to be oversold (<=20).

Yamana Gold’s Stock Yearly Top and Bottom Value

Yamana Gold’s stock is valued at $4.84 at 08:34 EST, way under its 52-week high of $6.40 and way higher than its 52-week low of $3.70.

Yamana Gold’s Moving Average

Yamana Gold’s value is under its 50-day moving average of $5.17 and higher than its 200-day moving average of $4.73.

More news about Yamana Gold.

7. Cenovus Energy (CVE) – Premarket: -2.61%

NYSE ended the session with Cenovus Energy sliding 1.47% to $16.45 on Thursday, after four sequential sessions in a row of losses. NYSE slid 0.38% to $14,340.29, after four consecutive sessions in a row of losses, on what was a somewhat down trend exchanging session today.

Volume

Today’s last reported volume for Cenovus Energy is 10066100, 7.44% below its average volume of 10875400.

Cenovus Energy’s last close was $16.45, 33.96% under its 52-week high of $24.91.

The company’s growth estimates for the current quarter and the next is 744.4% and 300%, respectively.

Cenovus Energy’s Revenue

Year-on-year quarterly revenue growth grew by 74.3%, now sitting on 53.26B for the twelve trailing months.

Volatility

Cenovus Energy’s last week, last month’s, and last quarter’s current intraday variation average was a negative 2.45%, a negative 1.28%, and a positive 3.06%, respectively.

Cenovus Energy’s highest amplitude of average volatility was 2.45% (last week), 4.01% (last month), and 3.06% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cenovus Energy’s stock is considered to be overbought (>=80).

Cenovus Energy’s Stock Yearly Top and Bottom Value

Cenovus Energy’s stock is valued at $16.45 at 08:34 EST, way under its 52-week high of $24.91 and way higher than its 52-week low of $7.20.

Cenovus Energy’s Moving Average

Cenovus Energy’s worth is way below its 50-day moving average of $20.62 and higher than its 200-day moving average of $15.50.

More news about Cenovus Energy.

8. Lloyds Banking Group (LYG) – Premarket: -2.51%

NYSE ended the session with Lloyds Banking Group falling 0% to $1.99 on Thursday, following the last session’s downward trend. NYSE slid 0.38% to $14,340.29, after four sequential sessions in a row of losses, on what was a somewhat bearish trend trading session today.

Volume

Today’s last reported volume for Lloyds Banking Group is 10040800, 25.96% below its average volume of 13562400.

Lloyds Banking Group’s last close was $1.99, 33.67% under its 52-week high of $3.00.

Lloyds Banking Group’s Revenue

Year-on-year quarterly revenue growth declined by 6.4%, now sitting on 16.86B for the twelve trailing months.

Volatility

Lloyds Banking Group’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.51%, a negative 0.10%, and a positive 1.84%, respectively.

Lloyds Banking Group’s highest amplitude of average volatility was 1.18% (last week), 1.76% (last month), and 1.84% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Lloyds Banking Group’s stock is considered to be overbought (>=80).

Lloyds Banking Group’s Stock Yearly Top and Bottom Value

Lloyds Banking Group’s stock is valued at $1.99 at 08:34 EST, way below its 52-week high of $3.00 and above its 52-week low of $1.98.

Lloyds Banking Group’s Moving Average

Lloyds Banking Group’s value is below its 50-day moving average of $2.17 and way below its 200-day moving average of $2.47.

More news about Lloyds Banking Group.

9. Freeport (FCX) – Premarket: -2.47%

NYSE ended the session with Freeport rising 0.53% to $26.44 on Thursday while NYSE fell 0.38% to $14,340.29.

Volume

Today’s last reported volume for Freeport is 24831400, 19.12% above its average volume of 20844400.

Freeport’s last close was $26.44, 49.14% under its 52-week high of $51.99.

The company’s growth estimates for the present quarter and the next is 27.3% and 9%, respectively.

Freeport’s Revenue

Year-on-year quarterly revenue growth grew by 36.1%, now sitting on 24.6B for the twelve trailing months.

Volatility

Freeport’s last week, last month’s, and last quarter’s current intraday variation average was a negative 3.58%, a negative 1.58%, and a positive 3.15%, respectively.

Freeport’s highest amplitude of average volatility was 3.58% (last week), 3.16% (last month), and 3.15% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Freeport’s stock is considered to be overbought (>=80).

Freeport’s Stock Yearly Top and Bottom Value

Freeport’s stock is valued at $26.44 at 08:34 EST, way below its 52-week high of $51.99 and above its 52-week low of $26.21.

Freeport’s Moving Average

Freeport’s value is way under its 50-day moving average of $36.24 and way below its 200-day moving average of $40.15.

More news about Freeport.

10. Carnival Plc (CUK) – Premarket: -2.34%

NYSE ended the session with Carnival Plc sliding 1.04% to $8.12 on Thursday while NYSE fell 0.38% to $14,340.29.

Volume

Today’s last reported volume for Carnival Plc is 2606500, 19.86% below its average volume of 3252540.

Carnival Plc’s last close was $8.12, 70.27% under its 52-week high of $27.31.

Carnival Plc’s Revenue

Year-on-year quarterly revenue growth declined by 93.4%, now sitting on 141M for the twelve trailing months.

Volatility

Carnival Plc’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.02%, a negative 0.54%, and a positive 4.69%, respectively.

Carnival Plc’s highest amplitude of average volatility was 5.16% (last week), 6.06% (last month), and 4.69% (last quarter), respectively.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Carnival Plc’s stock is considered to be oversold (<=20).

Carnival Plc’s Stock Yearly Top and Bottom Value

Carnival Plc’s stock is valued at $8.12 at 08:34 EST, way under its 52-week low of $15.16.

Carnival Plc’s Moving Average

Carnival Plc’s worth is way below its 50-day moving average of $20.03 and way below its 200-day moving average of $22.03.

More news about Carnival Plc.

Stay up to date with our premarket winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here